SEITO Biologics is a preclinical biotechnology startup.
SEITO Biologics has raised $3.4M in total funding. The most recent round was Seed. The last funding was announced in June 2025.
SEITO Biologics's investors include Lichtsteiner Foundation.
SEITO Biologics is headquartered in Zurich, Switzerland.
SEITO Biologics is a preclinical biotechnology startup.
SEITO Biologics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"SEITO Biologics — Funding & Investors." VCBacked, June 11, 2025, https://www.vcbacked.co/company/seito-biologics. Accessed October 30, 2026.
VCBacked. (2025). SEITO Biologics — Funding & Investors. Retrieved October 30, 2026, from https://www.vcbacked.co/company/seito-biologics
{{cite web |title=SEITO Biologics — Funding & Investors |url=https://www.vcbacked.co/company/seito-biologics |website=VCBacked |access-date=October 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated